あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/10/24 | 1,700 | 1,707 | 1,650 | 1,703 | +23 | +1.4% | 90,900 |
2023/10/23 | 1,690 | 1,693 | 1,670 | 1,680 | -37 | -2.2% | 62,300 |
2023/10/20 | 1,701 | 1,724 | 1,693 | 1,717 | +11 | +0.6% | 88,200 |
2023/10/19 | 1,669 | 1,714 | 1,664 | 1,706 | +39 | +2.3% | 110,800 |
2023/10/18 | 1,670 | 1,672 | 1,645 | 1,667 | -7 | -0.4% | 45,400 |
2023/10/17 | 1,697 | 1,707 | 1,647 | 1,674 | -12 | -0.7% | 71,100 |
2023/10/16 | 1,719 | 1,721 | 1,672 | 1,686 | -12 | -0.7% | 126,400 |
2023/10/13 | 1,703 | 1,704 | 1,683 | 1,698 | +6 | +0.4% | 96,200 |
2023/10/12 | 1,680 | 1,702 | 1,679 | 1,692 | +26 | +1.6% | 127,000 |
2023/10/11 | 1,679 | 1,683 | 1,654 | 1,666 | +9 | +0.5% | 67,200 |
2023/10/10 | 1,653 | 1,669 | 1,648 | 1,657 | +6 | +0.4% | 69,500 |
2023/10/06 | 1,656 | 1,678 | 1,649 | 1,651 | +12 | +0.7% | 68,200 |
2023/10/05 | 1,600 | 1,654 | 1,599 | 1,639 | +47 | +3% | 143,100 |
2023/10/04 | 1,609 | 1,627 | 1,584 | 1,592 | -35 | -2.2% | 143,900 |
2023/10/03 | 1,616 | 1,654 | 1,612 | 1,627 | +11 | +0.7% | 125,300 |
2023/10/02 | 1,677 | 1,685 | 1,615 | 1,616 | -80 | -4.7% | 221,000 |
2023/09/29 | 1,730 | 1,730 | 1,673 | 1,696 | -34 | -2% | 124,700 |
2023/09/28 | 1,735 | 1,755 | 1,716 | 1,730 | -33 | -1.9% | 148,700 |
2023/09/27 | 1,670 | 1,763 | 1,641 | 1,763 | +75 | +4.4% | 222,800 |
2023/09/26 | 1,725 | 1,735 | 1,683 | 1,688 | +38 | +2.3% | 224,500 |
2023/09/25 | 1,631 | 1,655 | 1,620 | 1,650 | +35 | +2.2% | 61,200 |
2023/09/22 | 1,622 | 1,624 | 1,609 | 1,615 | -11 | -0.7% | 61,600 |
2023/09/21 | 1,613 | 1,643 | 1,613 | 1,626 | +3 | +0.2% | 62,900 |
2023/09/20 | 1,654 | 1,655 | 1,617 | 1,623 | -36 | -2.2% | 108,600 |
2023/09/19 | 1,674 | 1,674 | 1,641 | 1,659 | -21 | -1.3% | 72,000 |
2023/09/15 | 1,655 | 1,688 | 1,646 | 1,680 | +26 | +1.6% | 82,700 |
2023/09/14 | 1,686 | 1,697 | 1,647 | 1,654 | +32 | +2% | 118,700 |
2023/09/13 | 1,654 | 1,664 | 1,611 | 1,622 | -45 | -2.7% | 251,700 |
2023/09/12 | 1,684 | 1,690 | 1,661 | 1,667 | -17 | -1% | 63,400 |
2023/09/11 | 1,679 | 1,684 | 1,666 | 1,684 | +17 | +1% | 51,700 |
2023/09/08 | 1,685 | 1,685 | 1,657 | 1,667 | ±0 | ±0% | 72,400 |
2023/09/07 | 1,672 | 1,677 | 1,661 | 1,667 | -5 | -0.3% | 88,100 |
2023/09/06 | 1,706 | 1,712 | 1,672 | 1,672 | -45 | -2.6% | 100,700 |
2023/09/05 | 1,710 | 1,717 | 1,700 | 1,717 | +7 | +0.4% | 59,200 |
2023/09/04 | 1,681 | 1,713 | 1,678 | 1,710 | +31 | +1.8% | 72,200 |
2023/09/01 | 1,676 | 1,688 | 1,673 | 1,679 | +3 | +0.2% | 63,600 |
2023/08/31 | 1,673 | 1,697 | 1,673 | 1,676 | +3 | +0.2% | 52,800 |
2023/08/30 | 1,682 | 1,685 | 1,666 | 1,673 | -7 | -0.4% | 55,900 |
2023/08/29 | 1,680 | 1,694 | 1,671 | 1,680 | +9 | +0.5% | 57,600 |
2023/08/28 | 1,661 | 1,680 | 1,661 | 1,671 | +8 | +0.5% | 38,400 |
2023/08/25 | 1,664 | 1,669 | 1,660 | 1,663 | -17 | -1% | 37,900 |
2023/08/24 | 1,669 | 1,690 | 1,667 | 1,680 | +11 | +0.7% | 49,400 |
2023/08/23 | 1,664 | 1,674 | 1,650 | 1,669 | +3 | +0.2% | 57,300 |
2023/08/22 | 1,655 | 1,667 | 1,646 | 1,666 | +19 | +1.2% | 48,800 |
2023/08/21 | 1,640 | 1,672 | 1,640 | 1,647 | +11 | +0.7% | 49,600 |
2023/08/18 | 1,641 | 1,652 | 1,623 | 1,636 | -23 | -1.4% | 62,200 |
2023/08/17 | 1,701 | 1,701 | 1,644 | 1,659 | -49 | -2.9% | 93,400 |
2023/08/16 | 1,680 | 1,727 | 1,666 | 1,708 | +28 | +1.7% | 108,200 |
2023/08/15 | 1,651 | 1,694 | 1,651 | 1,680 | +28 | +1.7% | 62,300 |
2023/08/14 | 1,695 | 1,700 | 1,647 | 1,652 | -42 | -2.5% | 99,700 |
401~
450
件表示中 / 1029件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
タウンズ | 56,800円 | +4.6% | +6.1% | 4.93% | 9.68倍 | 3.58倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
ヘリオス | 54,100円 | +150.0% | - | 0.00% | - | 26.61倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム